Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 12/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38663550 | 1.00 | DNM1 (0.40) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38662666 | 0.96 | DNM1 (0.43) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38662072 | 0.96 | DNM1 (0.41) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38662500 | 0.96 | DNM1 (0.41) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38664642 | 0.92 | CYP3A4 (0.37) | TLR2CYP3A4TSHRATMTDP1 | |
| SCHEMBL38665202 | 0.92 | CYP3A4 (0.37) | TLR2CYP3A4TSHRATMTDP1 | |
| SCHEMBL38663670 | 0.92 | DNM1 (0.44) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38663246 | 0.91 | ALDH1A1 (0.41) | DNM1TLR2CYP3A4TSHRATM | |
| SCHEMBL38661468 | 0.90 | TLR2 (0.46) | DNM1TLR2ACHE | |
| SCHEMBL38664732 | 0.89 | DNM1 (0.43) | DNM1TLR2CYP3A4TSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098671-A1 | CATIONIC LIPIDS AND PREPARATION METHOD THEREOF | RIBOX THERAPEUTICS HK LIMITED (CN) | 2026-05-15 | — | — | WO | disclosed |